Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Geologica Closes Financing And Property Acquisition (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Avivagen Inc V.VIV

Alternate Symbol(s):  VIVXF

Healthcare
Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is... see more

Recent & Breaking News (TSXV:VIV)

Crystal Research Associates, LLC Issues Executive Informational Overview on Avivagen Inc.

Marketwired March 8, 2017

Avivagen Inc. Announces Filing of Meeting Materials, Details of Proposed Share Consolidation and Change of Auditors

TheNewsWire March 3, 2017

Avivagen Announces Grant of Stock Options

TheNewsWire February 27, 2017

Avivagen Inc. Announces Results for the Quarter Ending January 31, 2017

TheNewsWire February 22, 2017

Avivagen Adds to Executive Team and Announces the Exercise of Warrants

TheNewsWire February 21, 2017

Avivagen Changes Leadership Team in Preparation for Global Scale Up and Commercialization

TheNewsWire February 9, 2017

Avivagen Undertakes Human Health Proof-of-Concept

TheNewsWire February 3, 2017

Vivendi : Information relative au nombre total de droits de vote et d’actions composant le capital social

Business Wire January 5, 2017

Avivagen Inc. Announces Results for Fiscal Year Ending October 31, 2016

TheNewsWire December 23, 2016

Vivendi détient 28,80 % du capital et 29,94 % des droits de vote de Mediaset

Business Wire December 22, 2016

Vivendi Owns 28.80% of the Mediaset Share Capital and 29.94% of the Voting Rights

Business Wire December 22, 2016

Vivendi owns 25.75% of the Mediaset share capital and 26.77% of the voting rights

Business Wire December 20, 2016

Vivendi détient 25,75 % du capital et 26,77 % des droits de vote de Mediaset

Business Wire December 20, 2016

Vivendi reached the 20% threshold of Mediaset

Business Wire December 14, 2016

Vivendi a atteint le seuil de 20 % de Mediaset

Business Wire December 14, 2016

Vivendi a franchi le seuil de 10 % du capital de Mediaset

Business Wire December 13, 2016

Vivendi Has Crossed the 10% Share Threshold in Mediaset

Business Wire December 13, 2016

Vivendi a franchi le seuil de 25 % du capital d’Ubisoft

Business Wire December 7, 2016

Vivendi Exceeded the 25% Shareholding Threshold in Ubisoft

Business Wire December 7, 2016

Vivendi : Caroline Le Masne de Chermont, Directrice juridique du Groupe

Business Wire December 7, 2016